Article
CD209-336A/G promotor polymorphism and its clinical associations in sickle cell disease Egyptian Pediatric patients.
Hematology/oncology and stem cell therapy - 1 Jun 2018
Afifi Rasha Abdel-Raouf, Kamal Dina, Sayed Riham El, Ekladious Sherif M M, Shaheen Gehan H, Yousry Sherif M, Hussein Rania Elsayed
Abstract excerpt
OBJECTIVES: To detect the frequency of CD209 A>G polymorphism in sickle cell disease (SCD) Egyptian patients and to evaluate the use of CD209 A>G polymorphism as a genetic predictor of SCD clinical heterogeneity. METHODS: A total of 100 Egyptian children with SCD and 100 Egyptian controls were tested for CD209 A>G polymorphism and were followed up prospectively between June 2012 and December 2014. RESULTS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.